Search results
36 Results for 'COVID-19'
- Technologies (7)
- Team (0)
- News (23)
- Events (0)
- Multimedia (6)
- Publications (0)
- Jobs (0)
Technologies 7
-
NAB-SPEAR: Measuring the Strength of COVID-19 Immune Responses
Vaccinations to protect people from the novel SARS-CoV-2 virus are well underway, but many outstanding questions have yet to be answered: how can a patient know if their body has mounted an effective immune response? How long does that immune response last? Is a person “safe” from COVID-19 after their first vaccine dose? Will their... -
Broad-Spectrum RNA Therapeutic for COVID-19 and Influenza
The COVID-19 pandemic has killed more than two million people worldwide and death tolls continue to mount due to the lack of an effective prevention, cure, or widespread vaccine for the disease. Influenza viruses have been even more deadly in the past, and still cause hundreds of thousands of deaths every year. Seasonal flu vaccines... -
OMNIVAX: Broadly Deployable Infection Vaccine Platform
Infectious diseases pose one of the greatest threats to public health, and vaccination campaigns with broad population coverage – arguably the most powerful strategy for preventing, controlling, and treating infectious diseases – have eradicated or significantly reduced the risk of contracting diseases such as smallpox, measles, polio, and tetanus. However, there is a constant need for... -
Using Systems Biology to Find and Test New Drugs Faster
The pharmaceutical industry is infamous for big numbers: it takes 10-15 years and can cost over $2 billion to bring a new drug from the lab to the market. Up to 6 of those years and $1 billion are spent in laborious preclinical trials to identify and validate new potential drug compounds, and much of... -
INSPECTR™: Direct-to-Consumer Molecular Diagnostic
Molecular diagnostics is the fastest growing segment of the global in vitro diagnostics market. There remains a gap, however, in providing this technology directly to consumers in a format that is as cost effective and as simple to use as a lateral flow immunoassay, like glucose and pregnancy tests. Scientists at the Wyss Institute have... -
FcMBL: Broad-Spectrum Pathogen Capture for Infectious Diseases
Microbial infection is the cause of life-threatening cases of sepsis, meningitis and multiple other diseases that are major causes of death world-wide. Equally prevalent are pathogenic contaminants in our environment, food, and manufacturing processes. In each case, the presence of dangerous microbes must be confirmed, and when they are found, they need to be removed,...
News 23
Multimedia 6
-
Video/AnimationOMNIVAX: Infection Vaccine PlatformThis video explains how OMNIVAX – an immuno-material-based vaccine technology can be used to rapidly create injectable vaccines against diverse viral and bacterial pathogens, and how the platform is used by the team to develop a vaccine against recurring urinary tract infections (UTIs) in their lead human application. Credit: Wyss Institute at Harvard University.
-
Video/AnimationBeating Back the Coronavirus: Face Shields for Frontline Healthcare WorkersThere is a national shortage of personal protective equipment (PPE) for frontline healthcare workers battling the COVID-19 pandemic. Researchers from the Jennifer Lewis Lab at the Harvard School of Engineering and Applied Sciences and Wyss Institute at Harvard University self-assembled into a team manufacturing greatly needed face shields for local hospitals. Credit: Wyss Institute at...
-
Audio/PodcastTalking Techniques: Donald Ingber: How COVID-19 is changing conservatism in life sciences (Part 2)Following on from part 1 of this interview with the Founding Director of the Wyss Institute, Donald Ingber discusses the reasons he thinks organ-on-a-chip technologies are yet to be widely implemented in research. Expanding on elements of conservatism rooted in certain aspects of the life sciences, Donald explores how the scientific response to the current COVID-19 pandemic is challenging entrenched...
-
Video/AnimationBeating Back the CoronavirusWhen the coronavirus pandemic forced Harvard University to ramp down almost all on-site operations, members of the Wyss Institute community refocused their teams, and formed new ones, in order to fight COVID-19 on its multiple fronts. These efforts include building new pieces of personal protective equipment that were delivered to frontline healthcare workers, developing new...
-
Audio/PodcastLab Notes #1 | A wearable diagnostic for COVID-19The Allen Institute is dedicated to answering some of the biggest questions in bioscience and accelerating research worldwide. They are a recognized leader in large-scale research with a commitment to openly sharing their data, tools and knowledge with scientists around the world. In the first episode of their podcast Lab Notes, they interview Wyss Core...
-
Audio/PodcastTalking Techniques: COVID-19, Organ Chips and the Wyss Institute (Part 1)In the first installment of this two-part episode with Donald Ingber, Founding Director of the Wyss Institute (MA, USA), we discuss his invention of organ-on-a-chip technology, how he is utilizing them in the fight against COVID-19 and the Wyss Institute’s response to the pandemic. Donald touches on the performance of the much-discussed chloroquine in his...